These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 776494)

  • 21. Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
    Cox JD; Byhardt RW; Komaki R; Greenberg M
    Int J Radiat Oncol Biol Phys; 1980 Jan; 6(1):37-40. PubMed ID: 6245044
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.
    Fowler JF; Sheldon PW; Denekamp J; Field SB
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):579-92. PubMed ID: 977399
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J
    Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxic cell radiosensitizers: expectations and progress in drug development.
    Coleman CN
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):323-9. PubMed ID: 3156109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.
    Urtasun RC; Band P; Chapman JD; Rabin HR; Wilson AF; Fryer CG
    Radiology; 1977 Mar; 122(3):801-4. PubMed ID: 841074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
    Taghian A; Lespinasse F; Guichard ME
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.
    Bleehen NM; Honess DJ; Morgan JE
    Br J Cancer; 1977 Mar; 35(3):299-306. PubMed ID: 856237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity and radiosensitization in mouse and man.
    Denekamp J
    Br J Radiol; 1978 Aug; 51(608):636-7. PubMed ID: 678761
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiotherapy combined with ICRF 159 (NSC 129943).
    Rhomberg WU
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):121-6. PubMed ID: 204615
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: The response of tumours to x rays and RO-07-0582.
    Thomlinson RH; Dische S; Gray Errington L
    Br J Radiol; 1976 Jun; 49(582):559. PubMed ID: 1276636
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
    Brown JM
    Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
    [No Abstract]   [Full Text] [Related]  

  • 32. Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159.
    Peters LJ
    Br J Radiol; 1976 Aug; 49(584):708-15. PubMed ID: 953390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation dose fractionation studies with hypoxic cell radiosensitizers using a murine tumor.
    Hill RP
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):483-5. PubMed ID: 7107371
    [No Abstract]   [Full Text] [Related]  

  • 34. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of cetuximab and fractionated irradiation on tumour micro-environment.
    Santiago A; Eicheler W; Bussink J; Rijken P; Yaromina A; Beuthien-Baumann B; van der Kogel AJ; Baumann M; Krause M
    Radiother Oncol; 2010 Nov; 97(2):322-9. PubMed ID: 20667608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.
    Sheldon PW; Foster JL; Fowler JF
    Br J Cancer; 1974 Dec; 30(6):560-5. PubMed ID: 4451633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of bladder carcinoma with irradiation combined with misonidazole.
    Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung metastasis suppression of the bifunctional new radiosensitizer KIN-806.
    Inomata T; Ogawa Y; Itoh S; Kariya S; Hamada N; Nishioka A; Yoshida S; Nagasawa H; Hori H; Inayama S
    Int J Mol Med; 1999 Sep; 4(3):257-60. PubMed ID: 10425275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
    Urtasun RC; Coleman CN; Wasserman TH; Phillips TL
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1691-6. PubMed ID: 6237083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in radiotherapy.
    Munzenrider JE
    Rev Interam Radiol; 1977 Jul; 2(3):123-33. PubMed ID: 408898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.